Innovex International (INVX) Cash & Equivalents (2016 - 2026)
Innovex International filings provide 17 years of Cash & Equivalents readings, the most recent being $203.4 million for Q4 2025.
- On a quarterly basis, Cash & Equivalents rose 177.58% to $203.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $203.4 million, a 177.58% increase, with the full-year FY2025 number at $203.4 million, up 177.58% from a year prior.
- Cash & Equivalents hit $203.4 million in Q4 2025 for Innovex International, up from $163.4 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $375.2 million in Q3 2021 to a low of $7.4 million in Q4 2023.
- Median Cash & Equivalents over the past 5 years was $131.6 million (2024), compared with a mean of $162.9 million.
- Biggest five-year swings in Cash & Equivalents: crashed 97.19% in 2021 and later skyrocketed 1102.54% in 2024.
- Innovex International's Cash & Equivalents stood at $9.7 million in 2021, then decreased by 13.56% to $8.4 million in 2022, then decreased by 12.0% to $7.4 million in 2023, then skyrocketed by 889.44% to $73.3 million in 2024, then surged by 177.58% to $203.4 million in 2025.
- The last three reported values for Cash & Equivalents were $203.4 million (Q4 2025), $163.4 million (Q3 2025), and $68.8 million (Q2 2025) per Business Quant data.